- Diseases
- Acoustic Neuroma (14)
- Adrenal Gland Tumor (24)
- Anal Cancer (68)
- Anemia (2)
- Appendix Cancer (16)
- Bile Duct Cancer (28)
- Bladder Cancer (68)
- Brain Metastases (28)
- Brain Tumor (236)
- Breast Cancer (714)
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (2)
- Cancer of Unknown Primary (4)
- Carcinoid Tumor (8)
- Cervical Cancer (158)
- Colon Cancer (166)
- Colorectal Cancer (106)
- Endocrine Tumor (4)
- Esophageal Cancer (40)
- Eye Cancer (36)
- Fallopian Tube Cancer (6)
- Germ Cell Tumor (4)
- Gestational Trophoblastic Disease (2)
- Head and Neck Cancer (2)
- Kidney Cancer (124)
- Leukemia (352)
- Liver Cancer (50)
- Lung Cancer (290)
- Lymphoma (286)
- Mesothelioma (14)
- Metastasis (30)
- Multiple Myeloma (102)
- Myelodysplastic Syndrome (64)
- Myeloproliferative Neoplasm (4)
- Neuroendocrine Tumors (16)
- Oral Cancer (102)
- Ovarian Cancer (172)
- Pancreatic Cancer (172)
- Parathyroid Disease (2)
- Penile Cancer (16)
- Pituitary Tumor (6)
- Prostate Cancer (146)
- Rectal Cancer (58)
- Renal Medullary Carcinoma (6)
- Salivary Gland Cancer (14)
- Sarcoma (234)
- Skin Cancer (294)
- Skull Base Tumors (54)
- Spinal Tumor (12)
- Stomach Cancer (58)
- Testicular Cancer (28)
- Throat Cancer (92)
- Thymoma (6)
- Thyroid Cancer (96)
- Tonsil Cancer (32)
- Uterine Cancer (78)
- Vaginal Cancer (14)
- Vulvar Cancer (18)
- Cancer Topic
- Adolescent and Young Adult Cancer Issues (20)
- Advance Care Planning (8)
- Advance Directives (4)
- Biostatistics (2)
- Blood Donation (18)
- Bone Health (8)
- COVID-19 (362)
- Cancer Recurrence (120)
- Childhood Cancer Issues (120)
- Clinical Trials (622)
- Complementary Integrative Medicine (20)
- Cytogenetics (2)
- DNA Methylation (4)
- Diagnosis (220)
- Epigenetics (6)
- Fertility (62)
- Follow-up Guidelines (2)
- Health Disparities (14)
- Hereditary Cancer Syndromes (126)
- Immunology (18)
- Li-Fraumeni Syndrome (8)
- Mental Health (114)
- Molecular Diagnostics (8)
- Pain Management (64)
- Palliative Care (8)
- Pathology (10)
- Physical Therapy (18)
- Pregnancy (18)
- Prevention (862)
- Research (402)
- Second Opinion (74)
- Sexuality (16)
- Side Effects (598)
- Sleep Disorders (10)
- Stem Cell Transplantation Cellular Therapy (216)
- Support (406)
- Survivorship (320)
- Symptoms (178)
- Treatment (1760)
Should You Consider Genetic Testing?
BY Mary Brolley
2 minute read | Published March 09, 2011
Medically Reviewed | Last reviewed by an MD Anderson Cancer Center medical professional on March 09, 2011
If you suspect that cancer "runs in your family," you may be curious about -- or even considering -- genetic testing.
This testing, which involves having a blood sample taken, can reveal DNA mutations that have been identified as causing certain types of cancer.
For some, the tests provide crucial knowledge. Those who test positive for a known cancer-causing mutation can address the risks head on with increased vigilance and screenings.
But testing is not for everyone, says Banu Arun, M.D., professor in the Department of Breast Medical Oncology and co-director of the Clinical Cancer Genetics Program at MD Anderson.
"Most cancers are not hereditary," she says. "For example, only about 10% of breast cancers are inherited. The rest are "sporadic" -- that is, they occur because of a confluence of factors."
That's why Arun suggests that before deciding to be tested, you consult a genetic counselor.
Counselors help assess the chances that a person will develop a disease such as cancer. Often, the first step in the process is making a family tree, then looking for such "red flags" as having had many relatives who:
- contracted cancer before age 50
- contracted more than one primary cancer, or
- had the same or a related cancer (for example, breast and ovarian).
She recommends that women who've been diagnosed with breast cancer and suspect it's hereditary get tested before beginning treatment.
"The results might indicate the risk of contralateral breast cancer (second new primary in the opposite breast) and help with surgical decision making, for example, considering bilateral mastectomy," she says.
"Also, new targeted drugs are in development that specifically target hereditary (BRCA-related) breast cancer, and patients might be eligible for these studies."
Related Cancerwise Stories
Most cancers are not hereditary.
Banu Arun, M.D.
Physician